158 related articles for article (PubMed ID: 35767216)
1. Evaluation of the Performance of the Gulf Cooperation Council Centralised Regulatory Review Process: Strategies to Improve Product Authorisation Efficiency and Quality.
Hashan HM; Al-Muteb SK; Alismail IA; Alsaleh ON; Alkherb ZM; McAuslane N; Walker SR
Pharmaceut Med; 2022 Aug; 36(4):223-231. PubMed ID: 35767216
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Gulf Cooperation Council Centralized Procedure: The Way Forward.
Al-Rubaie MH; Walker SR; Salek SS
Ther Innov Regul Sci; 2014 Nov; 48(6):709-716. PubMed ID: 30227472
[TBL] [Abstract][Full Text] [Related]
3. An Evaluation of the Efficiency of the Gulf Cooperation Council's Centralized Procedure by the Gulf Regulatory Authorities and Pharmaceutical Companies: Recommendations for an Improved Model.
Al-Rubaie MH; Salek S; Walker S
Ther Innov Regul Sci; 2015 Jul; 49(4):560-568. PubMed ID: 30222426
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients' Access to Medicines.
Keyter A; Salek S; Gouws J; Banoo S; Walker S
Ther Innov Regul Sci; 2020 Jul; 54(4):878-887. PubMed ID: 32557310
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.
Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
Front Pharmacol; 2022; 13():891506. PubMed ID: 35865962
[No Abstract] [Full Text] [Related]
6. Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Danks L; Nkambule P; Juma A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
Front Med (Lausanne); 2021; 8():742200. PubMed ID: 34513894
[No Abstract] [Full Text] [Related]
7. South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access.
Keyter A; Salek S; Danks L; Nkambule P; Semete-Makokotlela B; Walker S
Front Pharmacol; 2021; 12():699063. PubMed ID: 34366850
[No Abstract] [Full Text] [Related]
8. Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022.
Moeti L; Litedu M; Joubert J
J Pharm Policy Pract; 2023 Mar; 16(1):34. PubMed ID: 36864490
[TBL] [Abstract][Full Text] [Related]
9. Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal Products.
Borg JJ; Robert JL; Wade G; Aislaitner G; Pirozynski M; Abadie E; Salmonson T; Vella Bonanno P
J Pharm Pharm Sci; 2009; 12(2):181-98. PubMed ID: 19732496
[TBL] [Abstract][Full Text] [Related]
10. The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA).
Moeti L; Litedu M; Joubert J
Pharmaceut Med; 2023 Jan; 37(1):71-91. PubMed ID: 36598646
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients' Access to Medicines.
Koyuncu O; Gursoz H; Alkan A; Cetintas HC; Pasaoglu T; Mashaki Ceyhan E; Walker S
Front Pharmacol; 2019; 10():1557. PubMed ID: 32116658
[TBL] [Abstract][Full Text] [Related]
12. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
Sithole T; Mahlangu G; Walker S; Salek S
Front Med (Lausanne); 2022; 9():898725. PubMed ID: 35547215
[TBL] [Abstract][Full Text] [Related]
14. Barriers and facilitators to conducting economic evaluation studies of Gulf Cooperation Council (GCC) countries: a survey of researchers.
Almazrou SH; Alaujan SS; Al-Aqeel SA
Health Res Policy Syst; 2021 May; 19(1):71. PubMed ID: 33933093
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Food and Drugs Authority, Ghana Regulatory Review Process: Challenges and Opportunities.
Owusu-Asante M; Darko DM; Asamoah-Okyere KD; Asante-Boateng S; Kermad A; Walker S; Salek S
Ther Innov Regul Sci; 2023 Mar; 57(2):372-385. PubMed ID: 36352343
[TBL] [Abstract][Full Text] [Related]
16. The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland.
Keyter A; Salek S; Banoo S; Walker S
Front Pharmacol; 2019; 10():228. PubMed ID: 30923501
[No Abstract] [Full Text] [Related]
17. Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry.
Owusu-Asante M; Darko DM; Walker S; Salek S
Front Pharmacol; 2023; 14():1184108. PubMed ID: 37229251
[No Abstract] [Full Text] [Related]
18. Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities.
Sithole T; Mahlangu G; Salek S; Walker S
Ther Innov Regul Sci; 2021 May; 55(3):474-489. PubMed ID: 33387356
[TBL] [Abstract][Full Text] [Related]
19. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
[TBL] [Abstract][Full Text] [Related]
20. The development, implementation and evaluation of clinical practice guidelines in Gulf Cooperation Council (GCC) countries: a systematic review of literature.
Koornneef E; Robben P; Hajat C; Ali A
J Eval Clin Pract; 2015 Dec; 21(6):1006-13. PubMed ID: 25756849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
